Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.
Carlsquare Equity Research has published an initial coverage report on Pila Pharma, a biotech developing a pill-based agent for e.g., metabolic diseases, and currently preparing for clinical trials in obesity.
Read the full report here.